GCKR
Glucokinase regulatory protein
Also known as: GCKR_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q14397
- Gene
- GCKR
- Canonical length
- 625 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for GCKR in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
625 residues, UniProt reviewed canonical sequence.
>Q14397|GCKR
1 MPGTKRFQHV IETPEPGKWE LSGYEAAVPI TEKSNPLTQD LDKADAENIV RLLGQCDAEI
61 FQEEGQALST YQRLYSESIL TTMVQVAGKV QEVLKEPDGG LVVLSGGGTS GRMAFLMSVS
121 FNQLMKGLGQ KPLYTYLIAG GDRSVVASRE GTEDSALHGI EELKKVAAGK KRVIVIGISV
181 GLSAPFVAGQ MDCCMNNTAV FLPVLVGFNP VSMARNDPIE DWSSTFRQVA ERMQKMQEKQ
241 KAFVLNPAIG PEGLSGSSRM KGGSATKILL ETLLLAAHKT VDQGIAASQR CLLEILRTFE
301 RAHQVTYSQS PKIATLMKSV STSLEKKGHV YLVGWQTLGI IAIMDGVECI HTFGADFRDV
361 RGFLIGDHSD MFNQKAELTN QGPQFTFSQE DFLTSILPSL TEIDTVVFIF TLDDNLTEVQ
421 TIVEQVKEKT NHIQALAHST VGQTLPIPLK KLFPSIISIT WPLLFFEYEG NFIQKFQREL
481 STKWVLNTVS TGAHVLLGKI LQNHMLDLRI SNSKLFWRAL AMLQRFSGQS KARCIESLLR
541 AIHFPQPLSD DIRAAPISCH VQVAHEKEQV IPIALLSLLF RCSITEAQAH LAAAPSVCEA
601 VRSALAGPGQ KRTADPLEIL EPDVQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GCKR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 133 nTPM
Expression across tissuesHPA
Tissue
- liver: 133 nTPM
- adrenal gland: 6.6 nTPM
- stomach: 6.1 nTPM
- ovary: 5.7 nTPM
- testis: 2.6 nTPM
- gallbladder: 2.1 nTPM
Single-cell type
- hepatocytes: 166 nCPM
- foveolar cells: 40 nCPM
- esophageal apical cells: 39 nCPM
- pancreatic duct cells: 22 nCPM
- early spermatids: 15 nCPM
- pancreatic acinar cells: 11 nCPM
Immune cell
- basophil: 0.8 nTPM
- naive B-cell: 0.4 nTPM
- neutrophil: 0.4 nTPM
- NK-cell: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- intermediate monocyte: 0.2 nTPM
Brain region
- cerebellum: 17 nTPM
- medulla oblongata: 11 nTPM
- pons: 11 nTPM
- cerebral cortex: 11 nTPM
- hypothalamus: 10 nTPM
- midbrain: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.14
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular glucose homeostasis
- negative regulation of glucokinase activity
- protein import into nucleus
- protein localization to nucleus
- response to fructose
- response to glucose
- triglyceride homeostasis
- urate metabolic process
- carbohydrate derivative metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SIS domain
- SIS domain superfamily
- Glucokinase regulatory protein, conserved site
- N-acetylmuramic acid 6-phosphate etherase/glucokinase regulatory protein
- Glucokinase regulatory protein, second SIS domain
- C-terminal lid domain of glucokinase regulatory protein
- Glucokinase regulatory protein, second SIS domain
- Glucokinase regulatory protein N-terminal SIS domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GCKR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GCKR as an antibody target. Whether an autoantibody or antibody against GCKR could matter depends on whether native GCKR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GCKR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GCKR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...